LEADERS
CEO Sang Min Park
-
Dept. of Family medicine, Seoul National Universtiy / Ph.D.
-
Dept. of Family Medicine, Seoul National University Hospital, served as a Department Head
-
Health Promotion Center, Seoul National University Hospital, Head
-
Presidential Committee on The Fourth Industrial Revolution, Committee Member
-
Young Korean Academy of Science and Technology Member
-
Citations: 9,778, h-index: 52
-
SCI-level journals, the American Medical Association (JAMA), European Heart Journal (EHJ), the Journal of Clinical Oncology (JCO), 300 outstanding papers, including the Journal of the American Ophthalmology
-
Development of the world's first AI fundus arteriosclerosis diagnostic method
-
Development of XAI that can explain the diagnosis of glaucoma by innovatively solving the black box problem of artificial intelligence for the first time in the world
Paper
-
Presidential Committee on The Fourth Industrial Revolution, Digital Healthcare Special Committee Member
-
KCDC Korea Expert Committee on Immunization Practices Member
-
Young Korean Academy of Science and Technology Member
-
WONCA (World Organization of Family Doctors) co-editor general of the organizing committee
Exp.
-
Bum Seok Medical Award 26th, 2023.02
-
Seoul National University Hospital, Myeong Juwan Medical Research Award, Ji Seokyeong Research Award 2012, 2018, 2019
-
National Academy of Medicine of Korea, Pfizer Medical Research Award, 2019.11
-
Ministry of Health and Welfare, Cancer Prevention Day Minister's Commendation, 2012.03
-
Korean Academy of Medical Sciences Wunsch Medical Award Young Investigator Award, 2009.11
Achieve
CTO/RND Head Jooyoung Chang
-
Seoul National University Doctor of Medicine - PhD, Biomedical Sciences, General
-
Seoul National University Doctor of Medicine - MD, Medicine
-
Korea Advanced Institute of Science and Technology Bachelor's degree, Bio and Brain Engineering
-
Inthesmart - Senior Researcher
-
Citations: 659, h-index: 15
-
SCI-level journals, the American Medical Association (JAMA), European Heart Journal (EHJ), 300 outstanding papers, including the Journal of the American Ophthalmology
Paper
Patent
-
XAIMED Co., Ltd.'s key patents inventor
- METHOD FOR FACILITATING DIAGNOSIS OF FUNDUS IMAGE, APPARATUS THEREFOR AND SYSTEM INCLUDING THE SAME(Registration-No. 10-2306279)
- METHOD FOR FACILITATING VALIDATION OF VASCUALR DISEASE USING FUNDES IMAGE, APPARATUS THEREFOR AND SYSTEM INCLUDING THE SAME(Refistration-No. 10-2414994)
History
-
Establishment of clinically validated and explainable AI glaucoma diagnostic model
-
Development Model of Artificial Intelligence Software Based on Retinal Image
-
XAIMED Co., Ltd. Ophthalmic Image, computer aided detection/diagnosis software GMP Approved
-
XAIMED Co., Ltd. Manufacturer Business Approved.
HISTORY
2023
2021
2022
2020
~
2018
2020
05 Certification acquired for Verification of venture companies(R&D)
03 KFDA Medical Device Manufacturer Approved
01 Established Research Institute(Attached)
01 Registration Supplier Pool of "AI Boucher Support Project" from National IT Industry Promotion Agency
Certification acquired for Verification of venture companies(R&D)
KFDA Medical Device Manufacturer Approved
Established Research Institute(Attached)
Registration Supplier Pool of "AI Boucher Support Project" from National IT Industry Promotion Agency
09 Approved GMP of Standard of Medical Software manufacturing and quality management
06 Selected as participating company by Ministry of Health and Welfare's Medical AI Convergence Talent Training Project
06 Selected as consignment company by Korea Health Promotion Institute's Development and prove of O2O service model for Chronic disease management based on Digital Health
Approved GMP of Standard of Medical Software manufacturing and quality management
Selected as participating company by Ministry of Health and Welfare's Medical AI Convergence Talent Training Project
Selected as consignment company by Korea Health Promotion Institute's Development and prove of O2O service model for Chronic disease management based on Digital Health
11 XAIMED Co.,Ltd. - SAPIENMED Co.,Ltd. signed MOU
11 Selected by BT-IT Fusion Center's Video production support project
11 Selected by resident company of Digital healthcare Start-up Hub BT-IT Fusion Center from Korea Health Industry Development
09 Selected by Seoul Business Agency's Technical Commercialization Support Project
06 Issuance a Certification of Incorporation from Ministry of SMEs and Startup
04 BIO KOREA 2021 Biohealth Innovation Start-up Center Achievements Showcase
03 Press released about joint development of “Laparoscopy AI” with InTheSmart Co., Ltd. (11 news besides JoongAng Ilbo)
XAIMED Co.,Ltd. - SAPIENMED Co.,Ltd. signed MOU
Selected by BT-IT Fusion Center's Video production support project
Selected by resident company of Digital healthcare Start-up Hub BT-IT Fusion Center from Korea Health Industry Development
Selected by Seoul Business Agency's Technical Commercialization Support Project
Issuance a Certification of Incorporation from Ministry of SMEs and Startup
BIO KOREA 2021 Biohealth Innovation Start-up Center Achievements Showcase
Press released about joint development of “Laparoscopy AI” with InTheSmart Co., Ltd. (11 news besides JoongAng Ilbo)
11 Industry Development’s Institute Research Driven Hospital
11 Selected by Ministry of SMEs and Startup's Initial Startup Package Support Project, Korea Health Signed Technical Assistance Agreement with Seoul National University Hospital License
11 XAIMED Co., Ltd. - KOHELET Co., Ltd. signed MOU
09 Published "Retinal Fundus Images" paper at American Journal of Ophthalmology
06 Published "Deep Learning" paper at American Journal of Ophthalmology
04 XAIMED Co., Ltd. - INTHESMART Co., Ltd. signed MOU
03 Establishment of XAIMED Co., Ltd.
Industry Development’s Institute Research Driven Hospital
Selected by Ministry of SMEs and Startup's Initial Startup Package Support Project, Korea Health Signed Technical Assistance Agreement with Seoul National University Hospital License
XAIMED Co., Ltd. - KOHELET Co., Ltd. signed MOU
Published "Retinal Fundus Images" paper at American Journal of Ophthalmology
Published "Deep Learning" paper at American Journal of Ophthalmology
XAIMED Co., Ltd. - INTHESMART Co., Ltd. signed MOU
Establishment of XAIMED Co., Ltd.
Joint research of Artificial intelligence with INTHESMART Co., Ltd.
2018
~
2015
Established Health System Data Science Laboratory in Department of Biomedical Sciences, Seoul National University College of Medicine
PATENT / CERTIFICATIONS
Patent
- METHOD FOR FACILITATING DIAGNOSIS OF FUNDUS IMAGE, APPARATUS THEREFOR AND SYSTEM INCLUDING THE SAME (Registration-No. 10-2306279, Registration Date: 2021.09.23)
- METHOD FOR FACILITATING VALIDATION OF VASCULAR DISEASE USING FUNDUS IMAGE, APPARATUS THEREFOR AND SYSTEM INCLUDING THE SAME (Registration-No. 10-2414994, Registration Date: 2022.06.27)
APPARATUS AND METHODS FOR SUPPROTING READING OF FUNDUS IMAGE
(USA, Application No. 17/145,389, Application Date: 2021.01.10, Granted)
実時間生体イメージ認識方法及び装置
(JAPAN, Application No. 34008472, Application Date: 2022.01.24, Granted)
Endoscopic Tool Assembly and Endoscopic Apparatus Having the Same
(KOREA, Application No. 10-2021-0057088, Application Date: 2021.05.30, Granted)
Certifications
![[자이메드(주)] 증빙1.2_중소기업 확인서.png](https://static.wixstatic.com/media/ac1fe0_0ccc2c09527746fdb75366e95eb65c41~mv2.png/v1/fill/w_52,h_74,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/%5B%EC%9E%90%EC%9D%B4%EB%A9%94%EB%93%9C(%EC%A3%BC)%5D%20%EC%A6%9D%EB%B9%991_2_%EC%A4%91%EC%86%8C%EA%B8%B0%EC%97%85%20%ED%99%95%EC%9D%B8%EC%84%9C.png)
![[자이메드(주)] 증빙1.3_창업기업 확인서.png](https://static.wixstatic.com/media/ac1fe0_4405a10d25434abc96a6fe5544e7a8b7~mv2.png/v1/fill/w_52,h_74,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_avif,quality_auto/%5B%EC%9E%90%EC%9D%B4%EB%A9%94%EB%93%9C(%EC%A3%BC)%5D%20%EC%A6%9D%EB%B9%991_3_%EC%B0%BD%EC%97%85%EA%B8%B0%EC%97%85%20%ED%99%95%EC%9D%B8%EC%84%9C.png)
.png)
_%EA%B8%B0%EC%97%85%EB%B6%80%EC%84%A4%EC%97%B0%EA%B5%AC%EC%86%8C%20%EC%9D%B8%EC%A0%95%EC%84%9C_2023-05-16.png)
_GMP%20%EC%A0%81%ED%95%A9%EC%9D%B8%EC%A0%95%EC%84%9C.png)
R&D NETWORK
Health System Data Science Laboratory (HSDS)
The Health System Data Science Laboratory (HSDS) specializes in Big Data and Machine Learning pertaining to medicine. Located in Seoul National University Hospital, Seoul, Korea, HSDS is led by Prof. Sang Min Park of Seoul National University.
Clinical Big Data studies include the impact of various lifestyle behaviors, environmental factors, and medication on cardiovascular diseases, neurodegenerative diseases, and other health outcomes. Our team of researchers are highly capable of organizing research projects, data collection, data analysis, and modelling.
Machine Learning studies include the development and validation of deep learning models for cardiovascular disease and other biomarker detection using various image modalities.
Paper
Explaining the Rationale of Deep Learning Glaucoma Decisions with Adversarial Examples
Association of Cardiovascular Mortality and Deep Learning - Funduscopic Atherosclerosis Score Derived from Retinal Fundus Images
Laboratory History
2020
2019
2018
2017
2016
• Emissions lots of Ph.D. students
• Ophthalmology (IF: 8),
European Heart Journal (IF: 23),
Metabolism (IF: 6),
Diabetologia (IF: 7),
Environment International (IF: 7.5),
American Journal of Ophthalmology (IF: 4) including 30 papers
• Journal of The American College of Cardiology (IF: 20),
American Journal of Gastroenterology (IF: 10) including 26 papers
• Journal of American Medical Association (IF: 51),
European Heart Journal (IF: 23),
JAMA Internal Medicine (IF: 20) including 34 papers
• Journal of the American Heart Association,
International Journal of Cancer (IF: 7) including 13 papers
• Journal of Clinical Oncology (IF: 18) including 16 papers
2015
Professor, Health System Data Science Lab, Department of Biomedical Sciences, Seoul National University College of Medicine
Research Theme
1.Explainable Artificial Intelligence in Medicine
2.Health Impact of Environmental Pollution and Green Space
3.Health Impact of Human Behavior
4.Detection of detrimental effects of commonly used pharmaceuticals.
5.Discovery of novel benefits of commonly used pharmaceuticals.
Laboratory Member
Master/Doctoral Students: 6
CI
The XM symbol mark of XAIEMD Co., Ltd. was created by combining the letters of eXplainable AI and Medicine, representing the company's prominent image. It resolves the black box issue inherent in traditional AI and represents the most important element in enhancing the reliability of XAIMED's explainable artificial intelligence.
Symbol Mark
Korean_ Horizontal align
Regulation
Korean_ Vertical align
Korean Logotype
English Logotype
English Logotype
